GMDRWGQGTLVTVSS-(Leu-13C6,15N)

CAT:
804-HY-163993S
Size:
Inquire
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
GMDRWGQGTLVTVSS-(Leu-13C6,15N) - image 1

GMDRWGQGTLVTVSS-(Leu-13C6,15N)

  • UNSPSC Description:

    GMDRWGQGTLVTVSS-(Leu-13C6,15N) is the 13C and 15N labeled isotope of GMDRWGQGTLVTVSS[1].
  • Target Antigen:

    Isotope-Labeled Compounds
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Others
  • Field of Research:

    Others
  • Assay Protocol:

    https://www.medchemexpress.com/gmdrwgqgtlvtvss-leu-13c6-15n.html
  • Smiles:

    O=C(N[C@@H](CCSC)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC1=CNC2=CC=CC=C12)C(NCC(N[C@@H](CCC(N)=O)C(NCC(N[C@@H]([C@H](O)C)C([15NH][13C@@H]([13CH2][13CH]([13CH3])[13CH3])[13C](N[C@@H](C(C)C)C(N[C@@H]([C@H](O)C)C(N[C@@H](C(C)C)C(N[C@@H](CO)C(N[C@@H](CO)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CN
  • Molecular Weight:

    1600.71
  • References & Citations:

    [1]Russak, et sl. Impact of deuterium substitution on the pharmacokinetics of pharmaceuticals. Annals of Pharmacotherapy 53.2 (2019): 211-236.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported